nivolumab
bms
['nivo', 'nivolumab']
if you're at #asco23, check out the online abstract from dr. jing wu detailing her phase 2 trial that evaluates nivolumab in patients with recurrent idh-mutant gliomas with and without the hypermutation phenotype. learn more about the trial: 
Official Twitter account of @theNCI's Neuro-Oncology Branch at the National Institutes of Health (@NIH). Privacy Policy: https://t.co/QamKebns0j